Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
Using a technique combining Technetium-99 sulfur colloid and Lymphazurin Blue Dye, we have
established that the sentinel node predicts the pathology results of the rest of the
axillary lymph nodes. This minimally invasive technique, which can be readily performed
under local anesthesia, makes the need for full axillary lymph node dissection unnecessary
for most patients. If the sentinel node is negative, no further surgery is necessary. If
positive, a complete axillary node dissection is performed. In addition, the injections are
made while the patient is under anesthesia, reducing the physical and psychological pain
that accompanies injections done pre-operatively.
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To continue gathering data relating to the sentinel lymph node biopsy procedure.
Time of surgery and data analysis
V. Suzanne Klimberg, MD
University of Arkansas
United States: Institutional Review Board
|University of Arkansas for Medical Sciences||Little Rock, Arkansas 72205|